NURS 6630N Week 4 Assignment (2020) | NURS- 6630N Approaches to Treatment | Asian American Woman with Bipolar Disorder

NURS 6630N Week 4 Assignment (2020) Topic: Asian American Woman with Bipolar Disorder NURS- 6630N Approaches to Treatment 3/19/2020 Introduction Bipolar disorder is a chronic disease that can cause different symptoms which can affect the client and the caregivers. Despite multiple pharmacological interventions, many people with bipolar disorder (BD) experience substantial residual mood symptoms, even in the absence of severe mood episodes, which have a negative impact on the course of illness and quality of life. Limited data are available on how to optimize treatment for BD, especially for those who suffer from persistent and residual depressive symptoms (Hanssen, et al., 2019). Bipolar disorder (BD) is a disabling, chronic condition characterized by recurrent (hypo) manic, depressive, and/or mixed episodes, affecting approximately 1.2% of adult men and 1.4% of adult women (Hanssen, et al., 2019). Talking about suicide does not sound good and is disrespectful act to individual client in Asian society and the women are faced with this situation every day. Bipolar disorder is one of the leading causes of disability, and associated with considerable economic occupational and social burden. Similar to individuals with major depression, people with BD demonstrate a tendency to ruminate in response to negative affect which will result to client having ruminative thinking, decreased interest, and motivation, and a loss of positive effect which will result to increase in depressive symptoms. Approximately 60% of clients with BD relapse in a full mood episode within two years after recovering from the mood episode previous. The consistent mood symptoms affect the quality of the client’s life negatively so the client needs an additional psychological interventions which include Cognitive Behavioral Therapy (CBT) and is been effective for people with major depression or BD. Mindfulness-based Cognitive Therapy (MBCT) approaches haven recently shown to be effective for BD clients as one of the psychological treatment option as a way of preventing any relapse in client with Bipolar disorder. “Most patients with BD present initially to primary care providers, but through a lack of resources or expertise many do not receive an adequate evaluation for possible bipolar diagnosis” (Manning, 2010). Decision #1 Which decision did I select: As a provider the best decision that I will chose to begin client on Risperdal 1mg by mouth twice. Why did I select this decision: I wil - - - - - - - - - - - -- References Arcangelo, V. P., Perterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & William. Basco, M. R., & Rush, A. J. (2017). Cognitive-behavioral therapy for bipolar disorder. New York: Guilford Press. Beers, H. M., Porter, S. R., Jones, V. T., Kaplan, L. J., & Berkwits, M. (2015). The Merck Manual of diagnosis and therapy. (8th ed.). Whitehouse Station. NJ. Chen, R., Wang, H., Shi, J., Shen, K., & Hu, P. (2015). Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems. European Journal of Clinical Pharmacology, 71(7), 835-841. doi:10.1007/s. Dyga, K. (2019). Bipolar disorder and identity. Systematic review. Psychiatria Polska, 53(3), 691–707. Geddes J. R., &Miklowitz D. J. (2013). Treatment of bipolar disorder. Lancet, 381, 1672–1682. doi: 10.1016/S(13)60857-0. Hanssen, I., Huijbers, M. J., Lochmann-van Bennekom, M. W. H., Regeer, E. J., Stevens, A. W. M. M., Evers, S. M. A. A., Wensing, M., Kupka, R. W., & Speckens, A. E. M. (2019). Study protocol of a multicenter randomized controlled trial of mindfulness-based cognitive therapy and treatment as usual in bipolar disorder. BMC Psychiatry, 19(1), 130. Hammer, G. G., & McPhee, S. (2014). Pathophysiology of disease: An introduction to clinical Medicine. (7th ed.). New York, NY: McGraw-Hill Education. Fueentes, I., Rizo-Mendez, A., A, & James-Esparcia, A. (2016). Low compliance to Pharmacological treatment is linked to cognitive impairment in euthymic phase of Bipolar disorder. Journal of Affectiv e Disorders, 195, 215-220. https://doi .W Fountoulakis, K. N. (2014). Bipolar Disorder: An Evidence-Based Guide to Manic Depression. Springer. Feinstein, D., & Eden, D. (2011). Ethics Handbook for energy healing practitioners: A guide for the professional practice of energy medicine and energy psychology. Fulton, CA: Energy Psychology Press. Manning J. S. (2010). Tools to improve differential diagnosis of bipolar disorder in primary care. Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 17–22. doi:10.4088/PCC.9064su1c.03. McCormick, U., Murray, B., & McNew, B. (2015). Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. Journal of the American Association of Nurse Practitioners, 27(9), 530–542. Manning J. S. (2010). Tools to improve differential diagnosis of bipolar disorder in primary care. Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 17–22. doi:10.4088/PCC.9064su1c.03. Otto, M. W., Reilly-Harrington, N. A., & Knauz, R. O. (2011). Living with Bipolar Disorder: A Guide for Individuals and Families (Updated Edition). Oxford: Oxford University Press, USA. Sajatovic, M., Subramoniam, M., & Fuller, M. A. (2006). Risperidone in the treatment of bipolar mania. Neuropsychiatric Disease and Treatment, 2(2), 127–138. Stahl, S. M. (2013). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press. Valdes, M., Bertolin, S., Qian, H., Wong, H., Lam, R. W., & Tatham, L. N. (2019). Risperidone adjunctive therapy duration in the maintenance treatment of bipolar 1 disorder. A post hoc analysis. Journal of AffectiveDisorders, 246, 861.